Psychotropic Prescribing for Persons With Intellectual Disabilities and Other Psychiatric Disorders

被引:12
|
作者
Edelsohn, Gail A. [1 ]
Schuster, James M. [1 ]
Castelnovo, Kim [1 ]
Terhorst, Lauren [1 ]
Parthasarathy, Meghna [1 ]
机构
[1] Community Care Behav Hlth Org, Pittsburgh, PA USA
关键词
DEVELOPMENTAL-DISABILITIES; ANTIPSYCHOTIC MEDICATION; MENTAL-RETARDATION; PRIMARY-CARE; ADULTS; PREVALENCE; BEHAVIORS; PHARMACOTHERAPY; INDIVIDUALS; MANAGEMENT;
D O I
10.1176/appi.ps.201300029
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Prescribing patterns of psychotropic medication over a five-year period for Medicaid recipients (adults and children) with codiagnoses of an intellectual disability and a mental disorder were compared with patterns for those with sole mental disorder diagnoses. Methods: Each group was identified through paid behavioral health services claims. Four classes of medications (antidepressants, antipsychotics, benzodiazepines, and mood stabilizers) were examined in paid pharmacy claims. Diagnostic categories, rates of psychotropic prescription, and polypharmacy (three or more medications concurrently for 90 days or more) were compared by age group (child or adult). Results: Adults with mental disorders only (N=793 to 883; the range reflects the five study years) were prescribed antidepressants at a significantly higher rate compared with adults in the codiagnosis group (N=184 to 217). For three of the five study years, antipsychotics were prescribed to the sole-diagnosis group of adults at a significantly higher rate than to those with codiagnoses. Children in the group with codiagnoses (N=108 to141) were prescribed mood stabilizers at a significantly higher rate than the comparison group (N=638 to 728) in all five study years. Rates of antipsychotics prescribed were not statistically different between the two groups of children. Polypharmacy rates for both adults and children were higher for the codiagnosis group compared with the group with a sole mental disorder, but the difference did not reach statistical significance. Conclusions: Psychotropic prescribing patterns in the two groups studied varied by class of medication and age. Although evidence exists for using psychotropics to treat psychopathology and challenging behaviors among individuals with intellectual disabilities, consideration of behavioral intervention alternatives and careful monitoring of psychotropic effectiveness and side effects are recommended.
引用
收藏
页码:201 / 207
页数:7
相关论文
共 50 条
  • [1] Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities
    Dykens, Elisabeth M.
    Shah, Bhavik
    Davis, Bruce
    Baker, Courtney
    Fife, Taylor
    Fitzpatrick, Jeri
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2015, 7
  • [2] International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities
    Deb, Shoumitro
    Kwok, Henry
    Bertelli, Marco
    Salvador-Carulla, Luis
    Bradley, Elspeth
    Torr, Jennifer
    Barnhill, Jarret
    WORLD PSYCHIATRY, 2009, 8 (03) : 181 - 186
  • [3] Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study
    Henderson, Angela
    Mcskimming, Paula
    Kinnear, Deborah
    McCowan, Colin
    McIntosh, Alasdair
    Allan, Linda
    Cooper, Sally-Ann
    BMJ OPEN, 2020, 10 (09):
  • [4] Transitional challenges: Psychotropic medication and residential setting among young adults with intellectual disabilities
    Houseworth, James
    Ticha, Renata
    Pettingell, Sandra L.
    Stancliffe, Roger J.
    Bershadsky, Julie
    JOURNAL OF POLICY AND PRACTICE IN INTELLECTUAL DISABILITIES, 2024, 21 (03)
  • [5] Psychiatric Disorders in People With Intellectual Disabilities: Steps Toward Eliminating Research and Clinical Care Disparities
    Dykens, E. M.
    FIFTY YEARS OF RESEARCH IN INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2016, 50 : 277 - 302
  • [6] Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability
    Lunsky, Yona
    Modi, Miti
    PSYCHIATRIC SERVICES, 2018, 69 (02) : 242 - 246
  • [7] Repeat Emergency Department Visits for Individuals With Intellectual and Developmental Disabilities and Psychiatric Disorders
    Durbin, Anna
    Balogh, Robert
    Lin, Elizabeth
    Wilton, Andrew S.
    Selick, Avra
    Dobranowski, Kristin M.
    Lunsky, Yona
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2019, 124 (03): : 206 - 219
  • [8] Underdiagnosis of psychiatric disorders in people with intellectual disabilities: Differences between psychiatric disorders and challenging behaviour
    Pena-Salazar, Carlos
    Arrufat, Francesc
    Santos, Josep Manel
    Fontanet, Abel
    Gonzalez-Castro, Gretel
    Mas, Silvia
    Roura-Poch, Pere
    Valdes-Stauber, Juan
    JOURNAL OF INTELLECTUAL DISABILITIES, 2020, 24 (03) : 326 - 338
  • [9] Weight Status of Persons with Intellectual Disabilities
    Maaskant, Marian A.
    van Knijff-Raeven, Ankie G. M.
    Lantman-de Valk, Henny M. J. van Schrojenstein
    Veenstra, Marja Y.
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2009, 22 (05) : 426 - 432
  • [10] Assessment and Management of Patients with Intellectual Disabilities by Psychiatric Consultants
    Friedman, Nora D. B.
    Shedlack, Karen J.
    PSYCHOSOMATICS, 2011, 52 (03) : 210 - 217